Last reviewed · How we verify

NCT05509322: CARE

Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial

Withdrawn NA Last updated 12 April 2023
What this trial tests

NA trial testing Subsidy for fertility consult in Fertility Risk. Withdrawn.

Timeline
1 January 2023
Primary endpoint
10 April 2023
10 April 2023

Quick facts

Lead sponsorTurtle Health, Inc.
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Start date1 January 2023
Primary completion10 April 2023
Estimated completion10 April 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Turtle Health, Inc.

Who can join

Adults 25 to 35, female only, with Fertility Risk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This real-world, interventional sub-study will evaluate the impact of potential payer subsidies for Turtle Health at-home consults on subsequent interactions with the healthcare system within select sub-populations of interest.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Turtle Health, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing